JMP Securities Reaffirms Market Outperform Rating for Oracle (NYSE:ORCL)
otakuyassine3@gmail.com JMP Securities restated their market outperform rating on shares of Oracle (NYSE:ORCL – Free Report)...
Reaffirms
Cantor Fitzgerald Reaffirms Overweight Rating for Celldex Therapeutics (NASDAQ:CLDX)
Celldex Therapeutics (NASDAQ:CLDX – Get Free Report)‘s stock had its “overweight” rating restated by stock...